We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Workstation Provides Superior Pipetting Performance with Advanced Technologies

By LabMedica International staff writers
Posted on 01 Oct 2013
Print article
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
A new liquid handling platform provides superior performance for simple to complex pipetting needs, plus an integration option to simplify laboratory automation.

Hamilton Robotics (Reno, NV, USA) now offers the “Vantage” workstation, a highly flexible, multipurpose pipetting platform featuring a completely new, state-of-the-art linear motor design and contact-free NanoPulse pipetting technology covering a wide volume range (100 nL–1 mL). This affordable liquid handler is space-efficient and enables users to prepare samples with the utmost precision and traceability, helping to ensure downstream data reliability.


"The Hamilton VANTAGE caters to all market needs, from a low-cost pipettor to the most complex integrated system, and is field upgradable to cover the entire usability pyramid," said Jose Carle, vice president of Hamilton Robotics. Its expandable design also makes it a valuable instrument for labs with growing needs or new applications. Labs requiring increased walk-away time, high throughputs, or large capacities can upgrade their bench-top VANTAGE pipettor at any time with a Logistics Cabinet, which offers innovative tip and plate shuttling from below the pipetting deck and customizable, smart waste solutions.


A telescopic, vertical Track Gripper can also be added to transport samples from below- or off-deck third-party devices such as thermal cyclers, centrifuges, washers, readers, sealers, peelers, and incubators. "A single vertically integrated system can easily replace four to six other pipetting robots and offers much more functionality than competitor's platforms," said Alvaro Cuevas, VANTAGE Senior Product Manager. “Overall, this saves customers money and enables them to build process redundancy with a second robot at the same price point."


In addition to the hardware, INSTINCT V software brings ease of use to the next level with automation intelligence, making VANTAGE accessible to varying user levels. The graphical Assay Editor allows a user to program in a "lab person's language" while the XSL Editor can be used for more complex programming tasks. INSTINCT V's resource-optimized, dynamic Scheduler allows users to run the same or different assays in parallel on an instrument while other users connect remotely to write methods for new assays. INSTINCT V also provides remote system monitoring via smart phones, tablets, or any web-enabled device, which increases walk-away time for overnight and weekend runs.

Related Links:
Hamilton Robotics
VANTAGE Workstation



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.